DoW Breast Cancer, Breakthrough Award Level 4

The fiscal year 2026 Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. The research team must include two or more breast cancer consumer advocates, and clinical trials are required. The funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs. • The program announcement discusses the Breakthrough Award Level 4. • The research must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. • The estimated funding for this opportunity is $21,000,000. • The opportunity is open to any type of entity, subject to any clarification in the text field entitled "Additional Information on Eligibility".